BJL
UTHR icon

Brighton Jones LLC’s United Therapeutics UTHR Stock Holding History

Brighton Jones LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Sell
2,916
-204
-7% -$115K 0.03% 367
2026
Q1 		$1.85M Buy
+3,120
New +$1.55M 0.04% 287
2025
Q4 		– Sell
-1,502
Closed -$630K – 904
2025
Q3 		$630K Buy
1,502
+362
+32% +$122K 0.02% 548
2025
Q2 		$327K Buy
+1,140
New +$341K 0.01% 687

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Brighton Jones LLC's UTHR Position: Q2 2026 in Review

Brighton Jones LLC reduced its United Therapeutics (UTHR) stake by 6.5% in Q2 2026, selling an estimated $115K and leaving 2,916 shares worth $1.58M. The position accounts for 0.03% of the portfolio, ranked #367.

Brighton Jones LLC first reported a position in UTHR in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.85M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Brighton Jones LLC held 2,916 shares of United Therapeutics worth $1.58M as of Q2 2026.
  • Brighton Jones LLC sold 204 United Therapeutics shares in Q2 2026, an estimated $115K.
  • United Therapeutics made up 0.03% of Brighton Jones LLC's portfolio in Q2 2026, its #367 holding.
  • Brighton Jones LLC first reported a position in United Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Brighton Jones LLC's United Therapeutics position peaked at $1.85M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.